C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition
Ana Rita Lourenço,
M. Guy Roukens,
Danielle Seinstra,
Cynthia L. Frederiks,
Cornelieke E. Pals,
Stephin J. Vervoort,
Andreia S. Margarido,
Jacco van Rheenen and
Paul J. Coffer ()
Additional contact information
Ana Rita Lourenço: University Medical Center Utrecht
M. Guy Roukens: University Medical Center Utrecht
Danielle Seinstra: Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121
Cynthia L. Frederiks: University Medical Center Utrecht
Cornelieke E. Pals: University Medical Center Utrecht
Stephin J. Vervoort: University Medical Center Utrecht
Andreia S. Margarido: Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121
Jacco van Rheenen: Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121
Paul J. Coffer: University Medical Center Utrecht
Nature Communications, 2020, vol. 11, issue 1, 1-18
Abstract:
Abstract Extracellular signals such as TGF-β can induce epithelial-to-mesenchymal transition (EMT) in cancers of epithelial origin, promoting molecular and phenotypical changes resulting in pro-metastatic characteristics. We identified C/EBPα as one of the most TGF-β-mediated downregulated transcription factors in human mammary epithelial cells. C/EBPα expression prevents TGF-β-driven EMT by inhibiting expression of known EMT factors. Depletion of C/EBPα is sufficient to induce mesenchymal-like morphology and molecular features, while cells that had undergone TGF-β-induced EMT reverted to an epithelial-like state upon C/EBPα re-expression. In vivo, mice injected with C/EBPα-expressing breast tumor organoids display a dramatic reduction of metastatic lesions. Collectively, our results show that C/EBPα is required for maintaining epithelial homeostasis by repressing the expression of key mesenchymal markers, thereby preventing EMT-mediated tumorigenesis. These data suggest that C/EBPα is a master epithelial “gatekeeper” whose expression is required to prevent unwarranted mesenchymal transition, supporting an important role for EMT in mediating breast cancer metastasis.
Date: 2020
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-020-14556-x Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-14556-x
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-020-14556-x
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().